Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00224_DB01198_nanopub.RA3Vs7xzse19CW8NKxWDGZzwwbEqmWkn8IDTIH21U_Mm0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00224_DB01198 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00224_DB01198 label "DDI between Indinavir and Zopiclone - Indinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if indinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00224_DB01198]" assertion.
- drugbank_resource:DB00224_DB01198 identifier "drugbank_resource:DB00224_DB01198" assertion.
- drugbank_resource:DB00224_DB01198 title "DDI between Indinavir and Zopiclone - Indinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of zopiclone by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zopiclone if indinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB01198 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB01198 assertion.
- drugbank:DB00224 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00224_DB01198 assertion.